首页> 外文会议>IEEE Ultrasonics Symposium >Adherence of platelet and fibrin targeted ultrasound contrast bubbles to human blood clots in vitro
【24h】

Adherence of platelet and fibrin targeted ultrasound contrast bubbles to human blood clots in vitro

机译:血小板和纤维蛋白的粘附靶向超声对比泡沫对体外人类血栓

获取原文

摘要

The purpose of this study is to assess platelet and fibrin targeted ultrasound contrast microbubbles' ability to adhere to fresh platelet and platelet poor clots in vitro with the assistance of radiation force. Whole blood from healthy volunteers (25 ml) was collected and centrifuged at 1100 rpm for 15 min to separate platelet-rich plasma (PRP), which was separated and centrifuged (3000 rpm, 5 min) to get platelet poor plasma (PPP). Calcium and Thrombin from human plasma were added to form fresh blood clots with upregulated receptors. Platelet targeted (MRX44; ImaRx Therapeutics, Inc., Tucson, AZ), fibrin targeted (MRX802; ImaRx Therapeutics) or untargeted, control bubbles were added to the clots. Radiation force was employed, using a single-element transducer with continuous wave ultrasound (2.5–5 MHz, 100 kHz PRF, 30 s exposure, 50.20–123.65 kPap-p pressure), to push the bubbles onto the thrombi. The adherence of the microbubbles to the clots was facilitated by the targeting ligands present on the microbubbles that bind to receptors present in blood clots or thrombi. Attachment rates between the groups were determined using a microscope setup and compared using unpaired t-tests. The average number of bubbles attached per 1000 μm2 of clot area using MRX44 was 7.0 ± 4.21 bubbles and 2.72 ± 2.44 bubbles, respectively, in PRP and PPP clots. With MRX802 the corresponding attachment rates were 11.45 ± 8.52 and 9.25 ± 3.40 bubbles, while typically less than 2 control bubbles adhered per 1000 μm2 of clot area in either clot type. The differences in adherence rates were statistically significant for MRX802 compared to MRX44 and to controls in both PRP and PPP clots (p ≪ 0.05). Relative to controls more MRX44 bubbles adhered in PRP clots (p = 0.003) but not in PPP clots (p = 0.07). In conclusion, the in vitro attachment rates of bubbles targeted to human blood clots depend on target availabi--lity (i.e., platelet targeted bubbles do better in PRP than in PPP clots). Fibrin targeted bubbles showed the best adherence rates in this study.
机译:本研究的目的是评估血小板和纤维蛋白的靶向超声造影微泡的能力,在辐射力的辅助下,体外粘附到新鲜血小板和血小板差的凝块。收集来自健康志愿者(25mL)的全血,并以1100rpm离心15分钟,以分离富含血小板的血浆(PRP),分离并离心(3000rpm,5分钟)以获得血小板差的血浆(ppp)。加入来自人血浆的钙和凝血酶以形成具有上调的受体的新鲜血液凝块。血小板靶向(MRX44; IMARX Therapeutics,Inc.,Tucson,AZ),纤维蛋白靶向(MRX802; IMARX治疗剂)或未出现的控制泡沫加入凝块中。采用辐射力,使用单元素换能器,连续波超声(2.5-5MHz,100kHz PRF,30次曝光,50.20-123.65 kPap-P压力),将气泡推到血栓上。通过存在于存在于血液凝血凝血凝血块或血栓的受体上的微泡上的靶向配体促进微泡对凝块的粘附性。使用显微镜设置测定组之间的附接速率,并使用未配对的T检验进行比较。使用MRX44的每1000μM2的凝块区域的平均气泡数分别为7.0±4.21气泡,分别在PRP和PPP凝块中分别为2.72±2.44气泡。使用MRX802,相应的附接速率为11.45±8.52和9.25±3.40气泡,而通常在凝块类型中粘附每1000μm 2 粘附的控制气泡。与MRX44相比MRX802的粘附率的差异是统计学意义的,并在PRP和PPP凝块中控制(P«0.05)。相对于控制PPP凝块中的更多MRX44气泡(P = 0.003),但不在PPP凝块中(P = 0.07)。总之,靶向人血栓的气泡的体外附着速率取决于目标可用性 - Lity(即,血小板靶向泡沫在PPP凝块中比在PPP凝块中更好)。纤维蛋白靶向泡沫显示了本研究中最好的粘附率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号